Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients

Jong Hwan Wang1, Hyun Ja Kwon, Yong Ju Jang

  • 1Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

The Laryngoscope
|June 19, 2007
PubMed
Abstract

Insights

Human parainfluenza virus 3 (PIV3) may cause postviral olfactory dysfunction (PVOD). Researchers found PIV3 in 88% of PVOD patients, suggesting it as a potential cause of smell loss after a cold.

Area of Science:

  • Otolaryngology
  • Virology
  • Immunology

Background:

  • Postviral olfactory dysfunction (PVOD) is a common condition following upper respiratory infections.
  • The specific viral agents responsible for PVOD remain largely unidentified.
  • Human parainfluenza virus 3 (PIV3) is a potential candidate pathogen for PVOD.

Purpose of the Study:

  • To investigate the presence and persistence of PIV3 in the nasal mucosa of patients with PVOD.
  • To determine if PIV3 is a potential causative agent of postviral olfactory dysfunction.

Main Methods:

  • A case-control study involving 25 PVOD patients and 22 controls.
  • Inferior turbinate epithelial cells were collected via mucosal curettage.
  • PIV3 detection using seminested reverse-transcription polymerase chain reaction (RT-PCR).

Main Results:

  • PVOD symptoms included hyposmia (60%) and anosmia (40%), with onset typically within 3 months.
  • PIV3 was detected in 88.0% of PVOD patients' epithelial samples.
  • PIV3 was detected in only 9.1% of control subjects' samples.

Conclusions:

  • The high prevalence of PIV3 in PVOD patients strongly suggests its role as a causative agent.
  • These findings identify PIV3 as a significant viral contributor to olfactory dysfunction.
  • Further research into PIV3-specific treatments for PVOD is warranted.